Vertex Pharmaceuticals Incorporated (VRTX): $201.28

0.78 (+0.39%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VRTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 495

in industry

Vertex Pharmaceuticals Inc (VRTX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering VRTX.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
22 $331 $200 $260.91 $196.02 33.1%

The Trend in the Analyst Price Target


VRTX's average price target has moved down $24.67 over the prior 26 weeks.

VRTX reports an average of 28.8% for its upside potential over the past 13 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-17 22 331 200 260.91 202.28 28.98%
2021-07-10 22 331 200 260.91 198.16 31.67%
2021-07-03 22 331 200 260.73 200.54 30.01%
2021-06-26 21 331 200 262.90 194.34 35.28%
2021-06-13 21 347 205 271.29 193.02 40.55%
2021-06-05 23 358 250 285.39 209.93 35.95%
2021-05-22 23 358 250 285.39 213.43 33.72%
2021-05-15 22 358 250 285.55 217.09 31.54%
2021-05-08 22 347 250 284.68 215.01 32.4%
2021-04-25 24 347 250 284.88 217.90 30.74%
2021-04-17 24 347 250 285.50 219.39 30.13%
2021-04-10 25 347 250 284.88 213.35 33.53%
2021-04-03 25 347 250 284.84 213.04 33.7%
2021-03-20 25 347 250 284.84 216.11 31.8%
2021-03-13 26 347 250 284.73 214.33 32.85%
2021-03-06 26 347 250 284.73 211.98 34.32%
2021-02-27 26 347 250 284.73 212.55 33.96%
2021-02-20 26 347 220 283.50 207.02 36.94%
2021-02-13 26 347 220 283.89 213.98 32.67%
2021-02-06 26 347 220 283.89 215.26 31.88%
2021-01-30 26 343 220 285.65 229.08 24.69%
2021-01-23 26 343 220 285.65 237.59 20.23%
2021-01-16 26 343 220 285.58 225.55 26.61%
2021-01-09 26 343 220 285.58 237.00 20.5%
2021-01-02 26 356 220 287.27 236.34 21.55%
2020-12-26 25 356 220 288.76 234.46 23.16%
2020-12-19 25 356 220 288.76 236.72 21.98%
2020-12-09 25 356 220 288.44 224.38 28.55%
2020-12-07 25 356 220 288.44 227.06 27.03%
2020-11-20 24 356 220 287.75 215.21 33.71%
2020-11-19 24 356 220 287.96 211.97 35.85%
2020-10-30 23 356 220 288.48 208.36 38.45%
2020-10-30 23 357 220 288.52 208.36 38.47%
2020-09-30 22 340 245 307.41 272.12 12.97%
2020-09-23 22 340 245 307.41 263.82 16.52%
2020-09-06 22 340 245 307.41 266.50 15.35%
2020-08-26 22 340 245 307.41 271.29 13.31%
2020-08-08 21 340 245 308.19 272.99 12.89%
2020-07-20 22 340 245 296.41 NA NA%
2020-07-15 22 340 245 293.95 NA NA%
2020-07-08 22 330 245 290.32 NA NA%
2020-07-04 22 330 245 289.09 NA NA%
2020-06-23 22 330 245 287.27 NA NA%
2020-06-19 22 325 245 285.23 NA NA%
2020-06-11 23 325 245 285.09 NA NA%
2020-06-08 23 310 245 284.22 NA NA%

VRTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.44 9 12 6 0 0 27

The Trend in the Broker Recommendations


Over the past 39 weeks, VRTX's average broker recommendation rating worsened by 0.27.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Vertex Pharmaceuticals Inc's average analyst price target is higher than 95.94% of all US stocks.
  • The number of analysts covering the stock of VRTX is greater than 98.57% of Pharmaceutical Products stocks.
  • VRTX has a greater upside potential (average analyst target price relative to current price) than 87.67% of stocks in the large market cap category.
  • The variance in analysts' estimates of VRTX is less than 23.03% of all US stocks.

In the Pharmaceutical Products industry, NBIX, ABT and JNJ are the three stocks most similar to Vertex Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding VRTX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.82 seconds.